Panacea Pharma Projects Utilizes New Article Galaxy Widget from Reprints Desk in Support of Outsourced Pharmacovigilance Services Provided to European Clients
Los Angeles, CA, March 13, 2015 – Reprints Desk, Inc., a Research Solutions (OTCQB: RSSS) company and top-rated document delivery supplier for scientific, technical and medical (STM) information, has announced Panacea Pharma Projects, an outsourced pharmacovigilance and regulatory affairs supplier will adopt the company’s Article Galaxy Widget, a time-saving tool that provides web browser access to scientific, technology and medical (STM) research articles indexed by more than 50 popular search sites and discovery databases, like Google Scholar, PubMed, ResearchGATE, Web of Science and Scopus, as well as numerous publisher websites.
“Panacea Pharma Projects is always on the cutting edge of the pharmacovigilance industry, which is how we discovered Article Galaxy Widget from Reprints Desk,” said Sam Tipper, business development manager at Panacea. “Article Galaxy Widget supports our systematic monitoring of scientific literature with tools like PubMed, ensuring that we have the quickest means available to identify and access the full-text so we can continue our triage and documentation workflows.”
Launched as beta version in June 2014, Article Galaxy is already in use at dozens of research-oriented organizations—from Fortune 500 companies to boutique research firms in biotechnology and other industries. Article Galaxy Widget has also received widespread praise for its ease-of-use and advanced functionality, and was recently covered in the February 2015 article ‘The Ultimate Sophistication: Reprints Desk Launches its Article Galaxy Widget’ by research and advisory firm Outsell, Inc.
Researchers simply launch the Article Galaxy Widget as a browser bookmark while they are viewing any website that references published journal articles. The widget’s intelligent user interface standardizes the search and presentation of full-text articles, and can quickly source content from existing journal subscriptions, Open Access, tokens, past single article document purchases or time-limited rentals. The widget also features quick filtering by source type, instant pricing, and a “more like this” function that identifies related scholarly papers.
Corporations, academic institutions, and government organizations around the world rely on Reprints Desk and its online platform Article Galaxy for legal, low cost access to full-text STM content. Founded by Peter Derycz, who is also the founder of Infotrieve, Reprints Desk has ranked #1 overall and in each category in a document delivery vendor survey of buyers conducted by Outsell.
For more information about Article Galaxy Widget, visit info.reprintsdesk.com/widget101.
About Panacea Pharma Projects
Panacea, formed in 2008 with offices in both the UK and the Isle of Man, is responsible for licenses in every European Union country, and in other countries around the world. In addition to providing core pharmacovigilance services to companies at the clinical trial, Marketing Authorization application and the post authorization phases, Panacea also offers veterinary pharmacovigilance, medical device vigilance and regulatory affairs services. With a dedicated Quality Management function, all work – at every level – is checked, audited, and compared with best practice to ensure the highest standard of results.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk is a wholly owned subsidiary of Research Solutions, Inc.
About Research Solutions®
Research Solutions, Inc. (OTCQB:RSSS) and its wholly-owned subsidiary Reprints Desk, Inc. (www.reprintsdesk.com) are pioneers in providing on-demand access to scientific, technical, and medical (STM) information for life science companies, academic institutions, and other research intensive organizations. Our customers include 70% of the top 25 pharma companies in the world. Our cloud based software-as-a-service (SaaS) solution, Article Galaxy, provides customers with access to the over one million newly published articles each year in addition to the tens of millions of existing articles that have been published in the past, helping them to identify the content that is critical to their research. We help our customers create and speed discoveries, save time and money, and remain copyright compliant. We have arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, we also serve STM publishers by facilitating compliance with applicable copyright laws.
Important Cautions Regarding Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission, including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. The Company assumes no obligation to update the cautionary information in this release.